A Big Pharma Titan Prepares For the Next Generation
Roche looks to maintain leadership into a new generation of oncology.
Dividend Derby: Pfizer Vs. Merck
Merck may have an edge over Pfizer in protecting and growing dividends thanks to a low payout ratio and possible asset sales.
Can Bristol-Myers Squibb Beat the S&P in 2014?
Shares of Bristol-Myers Squibb (NYSE: BMY) have been performing well of late, but can it beat the S&P 500 in 2014?
Nestlé’s Hot Pockets Recall Highlights Rancho Feeding’s Frightening Food Problems
Nestlé just recalled 238,000 cases of Hot Pockets after the beef was determined to be “unfit” for humans. What three lessons can consumers learn from this debacle?
Dow Debate: Will Johnson & Johnson Crush Pfizer?
Johnson & Johnson and Pfizer are both great stocks, but which will come out ahead in 2014?